The North America DNA sequencing market is estimated to register a CAGR of 16.83% during the forecast period, 2021-2028. The increasing elderly population and prevailing chronic disorders majorly propel market growth.

NORTH AMERICA DNA SEQUENCING MARKET FORECAST 2021-2028

North America Market by Technology ( Sequencing by Synthesis, Ion Semiconductor Sequencing, Chain Termination Sequencing, Pyrosequencing, Sequencing by Ligation (Sbl), Single-molecule Real-time Sequencing (Smrt), Nanopore Sequencing, Other Technologies ) Market by Application ( Biomarker Discovery, Diagnostics, Reproductive Health, Personalized Medicine, Drug Discovery, Agriculture & Animal Research, Forensics, Other Applications ) Market by Product ( Instruments & Consumables, Sequencing Services, Bioinformatics ) Market by End-user ( Research Centers and Academic & Government Institutes, Pharmaceutical, Biotechnology Companies, Hospitals & Clinics, Other End-users ) by Geography.

Request free sample

The North America DNA sequencing market is estimated to register a CAGR of 16.83% during the forecast period, 2021-2028. The increasing elderly population and prevailing chronic disorders majorly propel market growth.north-america-dna-sequencing-market

To know more about this report, request a free sample copy.

The North America DNA sequencing market growth evaluation includes the analysis of Canada and the United States. In the United States, many private and public companies invest in personalized medicine and associated research activities. The favorable government policies and technological advancements drive growth, along with the rising R&D towards DNA sequencing and developing advanced technologies. For instance, Pacific Biosciences developed a third-generation sequencing, Single-Molecule Real-Time Sequencing (SMRT). It is an effective technique given the use of cost-effective chemicals. Further, cancer cases are on the rise in the country. In 2018, as per the National Cancer Institute, around 1,735,350 new cancer cases were diagnosed. The government is increasingly prioritizing enhanced cancer treatments, which further fuels the DNA sequencing market growth.

Moreover, the increasing investment in new drug discoveries and developments has supplemented DNA sequencing products’ demand. Besides, the rising per capita incomes promote market growth, along with the availability of skilled professionals and leading drug manufacturers.

Illumina Inc is a global manufacturer, distributor, and developer of solutions and products in life science methods and procedures. It provides whole-genome sequencing, NIPT, and genotyping to conduct microarray and whole-genome sequencing projects. Its extensive product portfolio has applications in molecular tests, advanced disease research, and drug development. Latin America, Europe, North America, and Asia-Pacific are the company’s operational areas, with its headquarters in San Diego, California, United States.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INCREASING NEED FOR DNA SEQUENCING IN ANIMALS & PLANT REPRODUCTION
        • TECHNOLOGICAL DEVELOPMENTS
        • GROWING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
        • PREVALENCE OF CANCER CASES
        • USAGE OF LIQUID BIOPSY APPLICATIONS
        • IMPLEMENTATION OF GENOME MAPPING PROGRAMS
      • KEY RESTRAINTS
        • ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
        • LIMITATIONS IN BIOINFORMATICS
        • SOCIAL AND ETHICAL ISSUES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON DNA SEQUENCING MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
    2. MARKET BY TECHNOLOGY
      • SEQUENCING BY SYNTHESIS
      • ION SEMICONDUCTOR SEQUENCING
      • CHAIN TERMINATION SEQUENCING
      • PYROSEQUENCING
      • SEQUENCING BY LIGATION (SBL)
      • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
      • NANOPORE SEQUENCING
      • OTHER TECHNOLOGIES
    3. MARKET BY APPLICATION
      • BIOMARKER DISCOVERY
      • DIAGNOSTICS
      • REPRODUCTIVE HEALTH
      • PERSONALIZED MEDICINE
      • DRUG DISCOVERY
      • AGRICULTURE & ANIMAL RESEARCH
      • FORENSICS
      • OTHER APPLICATIONS
    4. MARKET BY PRODUCT
      • INSTRUMENTS & CONSUMABLES
        • INSTRUMENTS & CONSUMABLES TYPE
          • CONSUMABLES
          • INSTRUMENTS
        • INSTRUMENTS & CONSUMABLES PLATFORM
          • NGS (NEXT GENERATION SEQUENCING)
            • RNA SEQUENCING
            • TARGETED RESEQUENCING
            • WHOLE-EXOME SEQUENCING
            • WHOLE-GENOME SEQUENCING
            • CHIP SEQUENCING
            • DE NOVO SEQUENCING
            • METHYL SEQUENCING
          • SANGER
        • SEQUENCING SERVICES
        • BIOINFORMATICS
    1. MARKET BY END-USER
      • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
      • PHARMACEUTICAL
      • BIOTECHNOLOGY COMPANIES
      • HOSPITALS & CLINICS
      • OTHER END-USERS
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ADAPTIVE BIOTECHNOLOGIES INC
        • AGILENT TECHNOLOGIES INC
        • ASURAGEN INC
        • BGI GENOMICS
        • BIO-RAD LABORATORIES INC
        • DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
        • EUROFINS SCIENTIFIC
        • HOFFMANN-LA ROCHE
        • ILLUMINA INC
        • MERCK KGAA
        • PACIFIC BIOSCIENCES OF CALIFORNIA INC
        • PERKINELMER INC
        • SIEMENS HEALTHINEERS AG
        • SPIRAL GENETICS INC
        • THERMO FISHER SCIENTIFIC INC
        • UBIQUITY GENOMICS INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – DNA SEQUENCING

    TABLE 2: NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA NGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA NGS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: NORTH AMERICA DNA SEQUENCING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: NORTH AMERICA DNA SEQUENCING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: LEADING PLAYERS OPERATING IN NORTH AMERICA DNA SEQUENCING MARKET

    TABLE 19: LIST OF MERGERS & ACQUISITIONS

    TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 22: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 7: NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, IN 2020

    FIGURE 16: NORTH AMERICA DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, IN 2020

    FIGURE 25: NORTH AMERICA DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 28: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 30: NORTH AMERICA NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 31: NORTH AMERICA NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 32: NORTH AMERICA NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 33: NORTH AMERICA NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 34: NORTH AMERICA NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 35: NORTH AMERICA NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 36: NORTH AMERICA INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)

    FIGURE 37: NORTH AMERICA DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)

    FIGURE 38: NORTH AMERICA DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)

    FIGURE 39: NORTH AMERICA DNA SEQUENCING MARKET, BY END-USER, IN 2020

    FIGURE 40: NORTH AMERICA DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 41: NORTH AMERICA DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)

    FIGURE 42: NORTH AMERICA DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

    FIGURE 43: NORTH AMERICA DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 44: NORTH AMERICA DNA SEQUENCING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 45: NORTH AMERICA DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 46: UNITED STATES DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 47: CANADA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY TECHNOLOGY
      • SEQUENCING BY SYNTHESIS
      • ION SEMICONDUCTOR SEQUENCING
      • CHAIN TERMINATION SEQUENCING
      • PYROSEQUENCING
      • SEQUENCING BY LIGATION (SBL)
      • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
      • NANOPORE SEQUENCING
      • OTHER TECHNOLOGIES
    2. MARKET BY APPLICATION
      • BIOMARKER DISCOVERY
      • DIAGNOSTICS
      • REPRODUCTIVE HEALTH
      • PERSONALIZED MEDICINE
      • DRUG DISCOVERY
      • AGRICULTURE & ANIMAL RESEARCH
      • FORENSICS
      • OTHER APPLICATIONS
    3. MARKET BY PRODUCT
      • INSTRUMENTS & CONSUMABLES
        • INSTRUMENTS & CONSUMABLES TYPE
          • CONSUMABLES
          • INSTRUMENTS
        • INSTRUMENTS & CONSUMABLES PLATFORM
          • NGS (NEXT GENERATION SEQUENCING)
            • RNA SEQUENCING
            • TARGETED RESEQUENCING
            • WHOLE-EXOME SEQUENCING
            • WHOLE-GENOME SEQUENCING
            • CHIP SEQUENCING
            • DE NOVO SEQUENCING
            • METHYL SEQUENCING
          • SANGER
        • SEQUENCING SERVICES
        • BIOINFORMATICS
    1. MARKET BY END-USER
      • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
      • PHARMACEUTICAL
      • BIOTECHNOLOGY COMPANIES
      • HOSPITALS & CLINICS
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type